Analysis of pancreatic cancer samples by immunohistochemistry has revealed an increased expression of GLI1, DNMT1 and DNMT3a in the cancer cells compared to normal cells [85]. This evidence concerns the gene GLI1 and familial pancreatic carcinoma.